Cravath, Wachtell Advise On J&J's $3.4B Auris Health Deal
A subsidiary of Johnson & Johnson has agreed to pay roughly $3.4 billion for private equity-backed Auris Health Inc., which develops robotic technologies for health care-related purposes, the companies said Wednesday, in...To view the full article, register now.
Already a subscriber? Click here to view full article